In our work to identify AKR1C1 inhibitors from natural products to overcome cisplatin-resistance in human non-small lung cancer cells (NSCLC), the chemical composition of the extracts from four parts of P. japonicum and their AKR1C1 inhibitory activities in NSCLC (A549) were examined. Here, AKR1C1 is linked to non-small cell lung carcinoma.